Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Hold
20
– – ﹤0.01% 810
2026
Q1
$9.6K Sell
20
-380
-95% -$195K ﹤0.01% 814
2025
Q4
$225K Sell
400
-2,220
-85% -$1.26M ﹤0.01% 663
2025
Q3
$1.35M Sell
2,620
-2,841
-52% -$1.24M ﹤0.01% 628
2025
Q2
$1.71M Sell
5,461
-1,239
-18% -$372K ﹤0.01% 624
2025
Q1
$2.04M Buy
6,700
+66
+1% +$22.2K 0.01% 656
2024
Q4
$2.2M Sell
6,634
-27,166
-80% -$9.21M 0.01% 632
2024
Q3
$11.3M Buy
33,800
+6,279
+23% +$2.39M 0.04% 366
2024
Q2
$11.3M Sell
27,521
-3,448
-11% -$1.37M 0.04% 345
2024
Q1
$12.5M Buy
+30,969
New +$10.9M 0.04% 374

Other funds holding MEDP

Danske Bank's MEDP Position: Q2 2026 in Review

Danske Bank held its Medpace (MEDP) position steady in Q2 2026 at 20 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Danske Bank first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.5M in Q1 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Danske Bank held 20 shares of Medpace worth $10.6K as of Q2 2026.
  • Danske Bank left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #810 holding.
  • Danske Bank first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Medpace position peaked at $12.5M in Q1 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.